Interaction of methylated LSD1 and CHD1, a compound inhibiting this interaction for use in therapy, and a screening method for such a compound
US10463630B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2016 |
| Grant date | Nov 5, 2019 |
| Priority date | — |
| Expiry date | May 30, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed in the present application are: (i) a compound inhibiting the interaction between LSD1me2 and CHD1 for use in therapy, (ii) a compound inhibiting the interaction between LSD1me2 and CHD1 for use in treating cancer, in particular prostate cancer, and (iii) a method of screening for such a compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.